Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 1 - General processes for the preparation of peptides
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
01/1997
01/07/1997US5591633 Nucleic acids encoding human placental coagulation inhibitor (PCI)
01/07/1997US5591593 Peptide sequence which binds to a mucin expressed by an epithelial tumor
01/07/1997US5591592 Method for detection of fibronectin receptor ligands
01/07/1997CA2025315C Protein-containing aqueous solutions
01/07/1997CA1338836C Endotoxin binding protein and uses thereof
01/03/1997WO1997000268A1 Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide
01/03/1997WO1997000267A1 Conformationally-restricted combinatorial library composition and method
01/03/1997WO1997000236A1 Multifunctional cross-linking reagents for hemoglobin, and cross-linked hemoglobin conjugates
01/02/1997EP0751220A1 Highly purified protein, production and use thereof
01/02/1997EP0751219A1 Platelet aggregation inhibitors
01/02/1997EP0750747A1 Identification of nucleotides, amino acids, or carbohydrates by mass spectrometry
01/02/1997EP0750667A1 Use of a recombinant inhibitor from erythrina caffra for purifying serine proteases
01/02/1997EP0750644A1 Water insoluble cross-linked polycarbonic acid compositions
01/02/1997EP0750632A1 Ion-channel forming amphiphilic peptides having n-terminal modifications
01/02/1997EP0750631A1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
01/02/1997EP0750629A1 Method and apparatus for performing multiple sequential reactions on a matrix
01/02/1997EP0477295B1 Platelet aggregation inhibitors
01/01/1997CN1033702C Method for extracting achyranthes bidentata glycopeptide
12/1996
12/31/1996US5589572 Process for production of inhibited forms of activated blood factors
12/31/1996US5589571 Process for production of inhibited forms of activated blood factors
12/31/1996US5589563 Surface-modifying endgroups for biomedical polymers
12/31/1996US5589452 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
12/31/1996US5589397 Method for monitoring the performance of an amino acid sequencer
12/31/1996US5589384 Formation of pentamer complex and binding to gangliosides and hinges of glycineproline and antigens or epitopes
12/31/1996US5589356 Cyclization
12/27/1996WO1996041881A1 Type f botulinum toxin and use thereof
12/27/1996WO1996041817A1 Collagen peptide fraction and its uses
12/27/1996WO1996041813A2 Functionalized polymers for site-specific attachment
12/27/1996EP0749440A1 Method of isolating and purifying a biomacromolecule
12/27/1996EP0749439A1 Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof
12/27/1996EP0749322A1 VACUOLATING TOXIN-DEFICIENT $i(H. PYLORI) AND RELATED METHODS
12/27/1996EP0332651B2 Method of isolating ca 125 antigen
12/27/1996CA2204726A1 Functionalized polymers for site-specific attachment
12/24/1996US5587471 Analyzing and evaluating phosphorus bearing monomeric units as to their suitability, coupling efficiency, in preparing random oligomer libraries; combinatorial chemistry
12/24/1996US5587360 Platelet adhesion inhibitor
12/24/1996US5587286 Methods and kits for detection of cells in food materials
12/19/1996WO1996041188A1 Compositions and methods of using terminally labeled peptides that bind mhc class i molecules
12/19/1996WO1996041185A1 Methods and compositions for binding endotoxins
12/19/1996WO1996041180A1 Anchor libraries and identification of peptide binding sequences
12/19/1996WO1996040920A1 Modified hemoglobin-like compounds and methods of purifying same
12/19/1996WO1996040912A1 Ob protein compositions and method
12/19/1996WO1996040784A2 Method of solubilizing, purifying, and refolding protein
12/19/1996WO1996040783A1 Separating unmodified hemoglobin from cross-linked hemoglobin
12/19/1996WO1996040782A1 Separation of hemoglobin on hydroxyapatite using hplc
12/19/1996WO1996040776A1 Methods for purifying authentic igf from yeast hosts
12/19/1996WO1996040773A1 Method for purifying thrombopoietin
12/19/1996WO1996040772A2 Agonist peptide dimers
12/19/1996WO1996040758A1 Process for recovering water-insoluble compounds from a fermentation broth
12/19/1996WO1996040752A1 Novel dolastatin derivatives, their preparation and use
12/19/1996WO1996040751A1 Novel dolastatin derivatives, their preparation and use
12/19/1996WO1996040740A1 Peptide and method of obtaining it
12/19/1996WO1996040736A1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding
12/19/1996WO1996040735A1 p-NITROBENZYL SIDE-CHAIN PROTECTION FOR SOLID-PHASE SYNTHESIS
12/19/1996WO1996040734A1 Process for cleavage of blocked peptide resins using liquid hydrogen fluoride
12/19/1996WO1996040733A1 A system and method for the modification and purification of peptides
12/19/1996WO1996040732A1 Combinatorial non-peptide libraries
12/19/1996WO1996040731A1 Pegylated modified proteins
12/19/1996WO1996040730A1 Preparation of an acylated protein powder
12/19/1996WO1996040289A1 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy
12/19/1996WO1996040248A1 Transvacular and intracellular delivery of lipidized proteins
12/19/1996WO1996040213A1 Manufacture and purification of peptides
12/19/1996WO1996040202A1 Synthesis of n-substituted oligomers
12/19/1996WO1996040201A1 Combinatorial libraries of substrate-bound cyclic organic compounds
12/19/1996WO1996040198A1 Synthesis of asparagine-linked glycopeptides on a polymeric solid support
12/19/1996WO1996040188A1 Reducing gelation of a fatty acid-acylated protein
12/19/1996WO1996040077A2 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby
12/19/1996CA2704354A1 Expression of lipoproteins
12/19/1996CA2628032A1 Agonist peptide dimers
12/19/1996CA2451973A1 Method of increasing the solubility of tissue factor pathway inhibitor
12/19/1996CA2451970A1 Method to aid refolding of tissue factor pathway inhibitor
12/19/1996CA2451969A1 Method of purifying tissue factor pathway inhibitor
12/19/1996CA2450953A1 Method of solubilizing, purifying, and refolding protein
12/19/1996CA2450804A1 Method of solubilizing, purifying, and refolding protein
12/19/1996CA2450800A1 Method of solubilizing, purifying, and refolding protein
12/19/1996CA2450797A1 Method of solubilizing proteins containing two oppositely-charged domains
12/19/1996CA2450795A1 Method of refolding tissue factor pathway inhibitor
12/19/1996CA2228277A1 Agonist peptide dimers
12/19/1996CA2223531A1 Reducing gelation of a fatty acid-acylated protein
12/19/1996CA2223495A1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding
12/19/1996CA2223389A1 Preparation of an acylated protein powder
12/19/1996CA2223183A1 Anchor libraries and identification of peptide binding sequences
12/19/1996CA2221508A1 Combinatorial libraries of substrate-bound cyclic organic compounds
12/19/1996CA2219242A1 Modified hemoglobin-like compounds and methods of purifying same
12/18/1996EP0748379A1 Modulators of anchoring protein function
12/18/1996EP0748337A1 Process for the obtention of a biological adhesive comprising fibrinogen, factor xiii and fibronectin
12/18/1996EP0748336A1 Immunosuppressive compounds and method of preparing same
12/18/1996EP0748335A1 Antibiotic stalobacins
12/18/1996EP0618802A4 Synthetic compounds and compositions with enhanced cell binding.
12/18/1996EP0513064B1 Manipulation of solid, semi-solid or liquid materials
12/18/1996CN1138349A Human activated protein C preparation and process for producing the same
12/18/1996CN1033584C Benzo-fused lactams that promote release of growth hormone
12/17/1996US5585360 Thrombin inhibitors
12/17/1996US5585351 T-cadherin adhesion molecule
12/17/1996US5585350 Thrombin-inhibitory protein from ticks
12/17/1996US5585275 Pilot apparatus for peptide synthesis and screening
12/17/1996US5585089 Humanized immunoglobulins
12/17/1996US5585069 Substrates with wells connected by channels controlled by valves, for concurrent analysis of several liquid samples
12/17/1996CA2006684C Monoclonal antibody against protein c
12/12/1996WO1996039539A1 Method and apparatus for determining consensus secondary structures for nucleic acid sequences
12/12/1996WO1996039503A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION
1 ... 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 ... 518